Skip to main content
OpenTrials

Clinical trial condition

Dermatitis, Atopic

Explore clinical trials studying Dermatitis, Atopic. Study availability and eligibility vary by location and protocol.

1,194 public trials 150 recruiting studies
Refine in advanced search Browse all conditions

Dermatitis, Atopic trial results

Completed

Effect of Lipikar Baume AP+M on Quality of Life and Pain of Adults With Dryness or Severe Xerosis

NCT05765461

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
Locations
  • Dermatology practices Zagreb, Croatia
  • Dermatology practices Berlin, Germany
  • Dermatology practices Lisbon, Portugal
  • Dermatology practices Pretoria, South Africa
View Trial Details
Completed

A Study to Assess the Efficacy and Safety of CMK389 in Patients With Moderate to Severe Atopic Dermatitis.

NCT04836858

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +10 more
Locations
  • Novartis Investigative Site Pardubice, Czech Republic, Czechia
  • Novartis Investigative Site Prague, Czechia
  • Novartis Investigative Site Marseille, France
  • Novartis Investigative Site Nice, France
View all 18 locations
View Trial Details
Completed

Tradipitant in Treatment-resistant Pruritus Associated With Atopic Dermatitis

NCT02651714

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +10 more
Locations
  • Vanda Investigational Site Encinitas, California, United States
  • Vanda Investigational Site Encino, California, United States
  • Vanda Investigational Site Lomita, California, United States
  • Vanda Investigational Site San Diego, California, United States
View all 28 locations
View Trial Details
Completed

Proof of Concept of VLY-686 in Subjects With Treatment-Resistant Pruritus Associated With Atopic Dermatitis

NCT02004041

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, Dermatitis, Atopic, +13 more
Locations
  • Vanda Investigational Site Düsseldorf, Germany
  • Vanda Investigational Site Hamburg, Germany
  • Vanda Investigational Site Jena, Germany
  • Vanda Investigational Site Kiel, Germany
View Trial Details
Completed

Efficacy and Safety of LEO 152020 Tablets for the Treatment of Adults With Moderate to Severe Atopic Dermatitis

NCT05117060

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
Locations
  • LEO Pharma Investigational Site Beverly Hills, California, United States
  • LEO Pharma Investigational Site Los Angeles, California, United States
  • LEO Pharma Investigational Site San Diego, California, United States
  • LEO Pharma Investigational Site Cincinnati, Ohio, United States
View all 45 locations
View Trial Details
Completed

Study to Evaluate Safety and Tolerability of PF-07242813 in Healthy Participants and Participants With Atopic Dermatitis

NCT04668066

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
Locations
  • Anaheim Clinical Trials, LLC Anaheim, California, United States
  • First OC Dermatology Fountain Valley, California, United States
  • Keck School of Medicine of USC Los Angeles, California, United States
  • USC/Norris Comprehensive Cancer Center Los Angeles, California, United States
View Trial Details

Related conditions